Interventions for Tuberculosis Control and Elimination 2002

814. Vynnycky E, Fine PEM. The annual risk of infection with Mycobacterium tuberculosis
in England and Wales since 1901. Int J Tuberc Lung Dis 1997; 1: 389-96.
815. Abel L, Cua VV, Oberti J, Lap VD, Due LK, Grosset J, Lagrange PH. Leprosy
and BCG in southern Vietnam. (Correspondence). Lancet 1990; 335: 1536.
816. Brown JAK, Stone MM, Sutherland I. BCG vaccination of children against leprosy
in Uganda: results at end of second follow-up. BMJ 1968; 1: 24-7.
817. Fine PEM, Maine N, Ponnighaus JM, Clarkson JA, Bliss L. Protective efficacy
of BCG against leprosy in northern Malawi. Lancet 1986; 2: 499-502.
818. Lwin K, Sundaresan T, Mg Gyi MG, Bechelli LM, Tamondong C, Gallego
Garbajosa P, Sansarricq H, Noordeen SK. BCG vaccination of children against
leprosy: fourteen-year findings of the trial in Burma. Bull World Health Organ
1985; 63: 1069-78.
819. Orege PA, Fine PEM, Lucas SB, Obura M, Okelo C, Okuku P. Case-control
study of BCG vaccination as a risk factor for leprosy and tuberculosis in Western
Kenya. Int J Leprosy 1993; 61: 542-9.
820. Sutherland I. Research into the control of tuberculosis and leprosy in the community.
Br Med Bull 1988; 44: 665-78.
821. Zodpey SP, Bansod BS, Shrikhande SN, Maldhure BR, Kulkarni SW. Protective
effect of Bacillus Calmette Guerin (BCG) against leprosy: a population-based
case-control study in Nagpur, India. Lepr Rev 1999; 70: 287-94.
822. Pönnighaus JM, Fine PEM, Bliss L, Gruer PJK, Kapira-Mwamondwe B, Msosa E,
Rees RJW, Clayton D, Pike MC, Sterne JAC, Oxborrow SM. The Karonga prevention
trial: a leprosy and tuberculosis vaccine trial in Northern Malawi. I.
Methods of the vaccination phase. Lepr Rev 1993; 64: 338-56.
823. Pönnighaus JM, Fine PEM, Sterne JAC, Wilson RJ, Msosa E, Gruer PJK,
Jenkins PA, Lucas SB, Liomba NG, Bliss L. Efficacy of BCG vaccine against
leprosy and tuberculosis in northern Malawi. Lancet 1992; 339: 636-9.
824. Black GF, Dockrell HM, Crampin AC, Floyd S, Weir RE, Bliss L, Sichali L,
Mwaungulu L, Kanyongoloka H, Ngwira B, Warndorff DK, Fine PEM. Patterns
and implications of naturally acquired immune responses to environmental and
tuberculous mycobacterial antigens in Northern Malawi. J Infect Dis 2001; 184:
322-9.
825. Stanford JL, Shield MJ, Rook GAW. How environmental mycobacteria may predetermine
the protective efficacy of BCG. Tubercle 1981; 62: 55-67.
826. Palmer CE, Long MW. Effects of infection with atypical mycobacteria on BCG
vaccination and tuberculosis. Am Rev Respir Dis 1966; 94: 553-68.
827. Edwards ML, Goodrich JM, Muller D, Pollack A, Ziegler JE, Smith DW.
Infection with Mycobacterium avium-intracellulare and the protective effects of
Bacille Calmette-Guérin. J Infect Dis 1982; 145: 733-41.
224